Gabriela V. Cohen Freue
Gabriela V. Cohen Freue
Associate Professor of Statistics, University of British Columbia
Verified email at stat.ubc.ca - Homepage
Title
Cited by
Cited by
Year
Genomic and proteomic expression analysis of Leishmania promastigote and amastigote life stages: the Leishmania genome is constitutively expressed
K Leifso, G Cohen-Freue, N Dogra, A Murray, WR McMaster
Molecular and biochemical parasitology 152 (1), 35-46, 2007
2562007
MRM‐based multiplexed quantitation of 67 putative cardiovascular disease biomarkers in human plasma
D Domanski, AJ Percy, J Yang, AG Chambers, JS Hill, GVC Freue, ...
Proteomics 12 (8), 1222-1243, 2012
2112012
Global gene expression in Leishmania
G Cohen-Freue, TR Holzer, JD Forney, WR McMaster
International journal for parasitology 37 (10), 1077-1086, 2007
1502007
Can we predict protein from mRNA levels?
N Fortelny, CM Overall, P Pavlidis, GVC Freue
Nature 547 (7664), E19-E20, 2017
1152017
Proteomic signatures in plasma during early acute renal allograft rejection
GVC Freue, M Sasaki, A Meredith, OP GŁnther, A Bergman, M Takhar, ...
Molecular & Cellular Proteomics 9 (9), 1954-1967, 2010
902010
Multiple reaction monitoring (MRM) principles and application to coronary artery disease
GV Cohen Freue, CH Borchers
Circulation: Cardiovascular Genetics 5 (3), 378-378, 2012
492012
Whole blood genomic biomarkers of acute cardiac allograft rejection
D Lin, Z Hollander, RT Ng, C Imai, A Ignaszewski, R Balshaw, GC Freue, ...
The Journal of heart and lung transplantation 28 (9), 927-935, 2009
482009
MDQC: a new quality assessment method for microarrays based on quality control reports
GV Cohen Freue, Z Hollander, E Shen, RH Zamar, R Balshaw, A Scherer, ...
Bioinformatics 23 (23), 3162-3169, 2007
432007
Computational biomarker pipeline from discovery to clinical implementation: plasma proteomic biomarkers for cardiac transplantation
GV Cohen Freue, A Meredith, D Smith, A Bergman, M Sasaki, KKY Lam, ...
PLoS computational biology 9 (4), e1002963, 2013
422013
Functional genomic analysis of peripheral blood during early acute renal allograft rejection
OP GŁnther, RF Balshaw, A Scherer, Z Hollander, A Mui, TJ Triche, ...
Transplantation 88 (7), 942-951, 2009
392009
Molecular signatures of end-stage heart failure
D Lin, Z Hollander, A Meredith, E Stadnick, M Sasaki, GC Freue, P Qasimi, ...
Journal of cardiac failure 17 (10), 867-874, 2011
342011
Plasma protein biosignatures for detection of cardiac allograft vasculopathy
D Lin, GC Freue, Z Hollander, GBJ Mancini, M Sasaki, A Mui, ...
The Journal of Heart and Lung Transplantation 32 (7), 723-733, 2013
292013
Predicting acute cardiac rejection from donor heart and pre-transplant recipient blood gene expression
Z Hollander, V Chen, K Sidhu, D Lin, RT Ng, R Balshaw, GV Cohen-Freue, ...
The Journal of Heart and Lung Transplantation 32 (2), 259-265, 2013
262013
A computational pipeline for the development of multi-marker bio-signature panels and ensemble classifiers
OP GŁnther, V Chen, GC Freue, RF Balshaw, SJ Tebbutt, Z Hollander, ...
BMC bioinformatics 13 (1), 1-18, 2012
262012
Whole blood biomarkers of acute cardiac allograft rejection: double-crossing the biopsy
Z Hollander, D Lin, V Chen, R Ng, J Wilson-McManus, A Ignaszewski, ...
Transplantation 90 (12), 1388-1393, 2010
262010
The Pitman estimator of the Cauchy location parameter
GVC Freue
Journal of Statistical Planning and Inference 137 (6), 1900-1913, 2007
262007
Serum proteomics in multiple sclerosis disease progression
H Tremlett, DLY Dai, Z Hollander, A Kapanen, T Aziz, ...
Journal of proteomics 118, 2-11, 2015
252015
Diagnostic performance of high-definition coronary computed tomography angiography performed with multiple radiation dose reduction strategies
B Heydari, J Leipsic, GBJ Mancini, JK Min, T LaBounty, C Taylor, ...
Canadian Journal of Cardiology 27 (5), 606-612, 2011
222011
A natural robustification of the ordinary instrumental variables estimator
GVC Freue, H Ortiz‐Molina, RH Zamar
Biometrics 69 (3), 641-650, 2013
212013
TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma
D Ennishi, S Healy, A Bashashati, S Saberi, C Hother, A Mottok, FC Chan, ...
Nature medicine 26 (4), 577-588, 2020
192020
The system can't perform the operation now. Try again later.
Articles 1–20